Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Experimental drug made available for stomach paralysis patients

NCT ID NCT04996134

First seen Jan 23, 2026 · Last updated May 19, 2026 · Updated 16 times

Summary

This program allowed patients aged 12 and older with severe stomach or gut problems like gastroparesis or GERD to try domperidone when standard treatments failed. The goal was to ease symptoms such as nausea, vomiting, and heartburn. The program is no longer available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROPARESIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Aurora BayCare Medical Center

    Green Bay, Wisconsin, 54311, United States

Conditions

Explore the condition pages connected to this study.